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ABSTRACT.
Purpose: To perform in vivo imaging of the Schlemm’s canal (SC) with anterior
segment spectral-domain optical coherence tomography [AS-spectral-domain
(SD)-OCT] and also to measure its biometric parameters including the SC
length and SC area in patients with pseudoexfoliation (PEX) glaucoma.
Methods: Forty-one consecutive patients with PEX glaucoma and 41 age- and
sex-matched normal subjects were enrolled. All subjects underwent imaging with
SD-OCT. The SC length and SC area were examined in the temporal sections
and measured with customized software.
Results: The percentages of the temporal sections in which SC was observable
were similar between the two groups. Mean SC length was found significantly
shorter, and mean SC area was found significantly smaller in patients with PEX
glaucoma than in controls (p = 0.044 and p = 0.036, respectively). Mean intra-
ocular pressure (IOP) values were also similar between two groups. No
significant correlations were found between SC measurements and IOP.
Conclusions: Anterior segment spectral-domain optical coherence tomography
offers non-invasive, in vivo measurement of the SC, and it could be used for
investigating the SC changes in patients with PEX glaucoma.
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Introduction
Pseudoexfoliation (PEX) syndrome is
biomicroscopically diagnosed by
abnormal fibrillar deposits on ocular
structures that line the aqueous-bathed
surfaces of the anterior segment (Ritch
& Schl€otzer-Schrehardt 2001). Pseu-
doexfoliation predisposes to a number
of ocular comorbidities, the most sev-
ere being glaucoma (Naumann et al.
1998). A previous histopathologic
study of the Schlemm’s canal (SC)
width with light and electron micro-
scopy in the eyes with PEX glaucoma
revealed that the SC tends to become
smaller in advanced cases (Johnson &
Matsumoto 2000).
Anterior segment optical coherence
tomography (AS-OCT) allows rapid
in vivo non-contact qualitative and
quantitative assessment of the human
anterior chamber, and recent improve-
ments in scan resolution have enabled
the identification of aqueous out-
flow structures, including the SC
(Asrani et al. 2008; Kagemann et al.
2010; Cheung et al. 2011; Usui et al.
2011).
Until now, in vivo evaluation of the
SC in patients with PEX glaucoma has
not been performed with any method.
Therefore, we aimed to perform in vivo
imaging of the SC with AS-spectral-
domain (SD)-OCT and also to measure
its biometric parameters including the




Forty-one consecutive patients with
PEX glaucoma who visited our
Department of Ophthalmology
between June 2014 and September
2015 were enrolled into the study.
Forty-one age- and sex-matched nor-
mal subjects were also studied, and one
eye was randomly selected as the nor-
mal control.
Written informed consent was
obtained from all participants. The
study was approved by the local ethics
committee and was performed in
accordance with the tenets of the Dec-
laration of Helsinki.
Inclusion criteria for PEX syndrome
included those with evident classical
dandruff or flaky exfoliation deposits
on the pupil, lens or other ocular
structures and radial pigment over the
lens surface with or without raised
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intra-ocular pressure (IOP) (Hong
et al. 2014). Glaucoma was defined as
those with glaucomatous optic neu-
ropathy evidenced by cupping, rim
thinning, notch or retinal nerve fibre
layer defects with corresponding visual
field defects (Hong et al. 2014). Sub-
jects were classified as having PEX
glaucoma if they had glaucoma and
PEX in either eye. Participants in the
control group were chosen from sub-
jects with no complaints and normal
ophthalmological examination.
Patients with any history of topical
or systemic medication usage that
could affect the drainage angle or
pupillary reflex, previous intra-ocular
surgery or laser treatment, ocular
trauma, uveitis, corneal scars and any
other pathology that could have led to




tions were conducted including slit-
lamp examination, applanation tonom-
etry (Goldmann; Haag-Streit, K€oniz,
Switzerland), stereoscopic evaluation
of the optic disc using a 90-dioptre lens
(Volk optical, Inc., Mentor, OH,
USA), measurements of axial length
(AL) and anterior chamber depth
(ACD) using the IOL Master (Carl
Zeiss Meditec, Dublin, CA, USA),
measurement of central corneal thick-
ness (CCT) using ultrasound pachyme-
try AccuPach V (Accutome ultrasound,
Inc., Malvern, PA, USA) and gonio-
scopy.
The morning IOP was measured
between 07:00 and 09:30. It was anal-
ysed specifically because it is typically
the time-point of the highest daily
pressure (Stewart et al. 2013).
Five measurements of AL and ACD
and three measurements of IOP and
CCT were performed to calculate the
mean values.
Medical/antiglaucomatous drug his-
tory and visual field test were used to
assess the stages of clinical severity of
glaucomatous damage, and eyes were
grouped according to these stages
(Johnson & Matsumoto 2000). Stage
1 eyes had mild disease, with a history
of elevated IOP and either the use of
one medication for treatment or no
treatment; stage 2 eyes had a history of
treatment with at least two medica-
tions, but did not have obvious disc
damage or visual field loss; stage 3 eyes
had mild-to-moderate visual field loss,
confined to either upper or lower
hemifields; and stage 4 eyes had
advanced field loss in both the upper
and lower hemifields.
Schlemm’s canal measurements using
spectral-domain optical coherence
tomography
Before pupil dilation, all subjects
underwent imaging with SD-OCT
(RTvue OCT; Optivue Inc, Toledo,
OH, USA) performed in dark room
conditions by an experienced investi-
gator (SI). The temporal limbus was
imaged after adjustment of the fixa-
tion to the nasal area. During the
examination, the subjects were
encouraged to open their eyes as
wide as possible, and if necessary,
the examiner gently helped them to
keep their eyes open using his fin-
gers, taking care to avoid putting
pressure on the eye. An eye speculum
was not used. If the eye nictitation
was noted during the examination,
the examination was repeated up to
three times (Usui et al. 2011).
Scans were obtained using the stan-
dard AS single scan protocol. In this
mode, each scan included 1024 axial A
scans with a total duration of 0.04 s on
a 3-mm line at 3 o’clock position for
optical density (OD) and 9 o’clock
position for OS (Fig. 1). For the final
B scan image (scan pattern: x = 3 mm
and z = 2 mm), 16 B scan images
(obtained from 1024 A scans) were
automatically obtained and averaged
to reduce speckle noise (from RTVue
User’s Manual provided by Optovue
Inc, Fremont, CA, USA). Cross-sec-
tional AS-OCT scans from the tempo-
ral section were acquired with the SD-
OCT device. Two experienced investi-
gators (SI and NYE) who were blind to
the groups of subjects evaluated the
images using customized software. On
the averaged B scan images, SC length
was defined as the avarage of the three
measurements of the axial length of the
thin, black and lucent space. The SC
area was depicted as the area sur-
rounded by the outline of SC (Hong
et al. 2013). Schlemm’s canal length
and SC area were measured manually
using only images in which SC was
completely observable.
Statistical analysis
Statistical analyses were performed
using the SPSS software version 16
(SPSS Inc., Chicago, IL, USA). The
variables were investigated using visual
(histograms, probability plots) and
analytical methods (Kolmogorov–
Smirnov/Shapiro-Wilk test) to deter-
mine whether or not they are normally
distributed. Descriptive analyses were
presented using means and standard
deviations for normally distributed
variables, and medians and interquar-
tile range for the non-normally dis-
tributed variables.
Comparisons between groups were
performed using the Student t-test and
Mann–Whitney U-test. The chi-
squared test or Fisher’s exact test,
where appropriate, was used to com-
pare the percentages between groups.
While investigating the associations
between non-normally distributed
and/or ordinal variables, the correla-
tion coefficients and their significance
were calculated using the Spearman
test. A p value of less than 0.05 was
considered statistically significant.
Accuracy for each SC measurement
was tested using intraclass correlation
coefficient (ICC) with the strength of
agreement scale described by Brennan
& Silman (1992). Accuracy was con-
sidered very good for ICC above 0.80
Fig. 1. Real-time optical coherence tomography image of the Schlemm’s canal (SC) obtained with
the line-scanning mode in the temporal quadrant after adjustment of the fixation to the nasal area.
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and good for ICC between 0.61 and
0.80.
Interobserver reliability was evalu-
ated by repetition of the SC measure-
ments by an ophthalmologist (NYE)
experienced in OCT blinded to previ-
ous measurements in a subsample of
20% of the main sample. These mea-
surements and the originals were com-
pared using ICC.
Intra-observer reliability was evalu-
ated by repetition of the SC measure-
ments by the main author blinded to
previous measurements in 20% of sub-
jects from the main sample. These pairs
of measurements were compared using
ICC.
Results
A total of 82 eyes from 82 subjects were
enrolled into the study, including 41
patients with PEX glaucoma and 41
age- and sex-matched normal controls.
The characteristics of the study sub-
jects are shown in Table 1. There were
no significant differences in IOP, AL
and CCT between the patients and
control group. However, a significantly
low ACD was found in patients with
PEX glaucoma when compared to
control group (p = 0.002).
In the temporal sections, mean SC
length was found significantly shorter
and mean SC area was found signifi-
cantly smaller in patients with PEX
glaucoma than in controls (p = 0.044
and p = 0.036, respectively) (Table 2).
An oblong-elliptic/ovate-elliptic black
space was visualized located close to
the trabecular meshwork (TM) in most
of the images generated using line
scan mode (Fig. 2). The percentages
of sections in which SC was observable
and SC area was measurable in both
groups are presented in Table 2.
Patients with PEX glaucoma were
grouped according to the glaucoma
stages. Number of eyes for stage 1, 2, 3
and 4 were 12, 6, 18 and 5, respectively.
The percentages of sections in which
SC was observable in control group,
patients with stage 1 + 2 and stage
3 + 4 PEX glaucoma were 87.8% (36/
41), 76.5% (13/17) and 62.5% (15/24),
respectively (p = NS). However, the
percentages of sections in which SC
area was measurable in control group,
patients with stage 1 + 2 and stage
3 + 4 PEX glaucoma were 82.9% (34/
41), 76.5% (13/17) and 54.2% (13/24),
respectively (p = 0.039).
Both SC length and SC area did not
correlate with the other parameters
including IOP, glaucoma stages, AL,
ACD and CCT.
Interobserver reliability was very
good for SC length and SC area, with
ICCs of 0.90 and 0.81, respectively.
Intra-observer reliability was also very
good for SC length and SC area, with
ICCs of 0.98 and 0.84, respectively.
Discussion
To our knowledge, this is the first
in vivo study evaluating biometric
parameters of SC in patients with
PEX glaucoma with AS-SD-OCT.
Both mean SC length and SC area
were found to be significantly
decreased in patients with PEX glau-
coma when compared to controls.
Irshad et al. (2010) performed
in vivo investigation of SC diameter in
glaucoma patients with ultrasound
biomicroscopy (UBM). Spectral/Four-
ier domain AS-OCT provides cross-
sectional views of the AS structures
with a resolution better than that of
UBM. Images and measurements of
very fine structures of the AS can be
achieved rapidly and non-invasively
(Zheng et al. 2011). Fuest et al. (2015)
evaluated early anatomical changes
following canaloplasty with AS-SD-
OCT and UBM. They concluded that
AS-OCT offers a high resolution for
imaging superficial conjunctival areas
and SC after canaloplasty, whereas
UBM is capable of detecting deeper
structures such as scleral lakes and
intra-canal sutures.
In the literature, there are AS-OCT
studies evaluating in vivo features of SC
in primary open-angle and angle-clo-
sure glaucoma (Hong et al. 2013; Rao
& Padhy 2014). In a study by Kage-
mann et al. (2010), SC areas imaged
with SD-OCT were found significantly
smaller in glaucoma patients than in
control subjects, leading to the possi-
bility that some of the findings may be
unrelated to the PEX material. We did
not include a group with primary open-
angle glaucoma. This was a major
limitation of our study.
Usui et al. (2011) identified SC and
its surrounding tissues in enucleated
human eyes by AS-Fourier domain-
OCT and histologic examination. Sch-
lemm’s canal length was determined as
354 lm on the OCT image and 384 lm
on histologic sections. Similarly, in our
study, the mean SC length was 349 lm.
The SC length measured in vivo may
reflect the canal’s functional size more
accurately because of partial collapse
of the canal secondary to physiological
conditions (Irshad et al. 2010).
Table 1. Characteristics of the study subjects.
Parameters PEXG patients (n: 41) Controls (n: 41) p
Age (years) 66.5 (8.7) 64.7 (7.6) NS
Gender (M:F) 23:18 23:18 NS
IOP (mmHg) 16 (13–19.5) 15 (13–18) NS
CCT (lm) 546.9 (35.5) 549.6 (31.4) NS
AL (mm) 23.1 (0.7) 23.3 (0.7) NS
ACD (mm) 2.8 (0.3) 3.0 (0.2) 0.002
Number of glaucoma drugs 2 (1–3) – –
Values were presented as mean (standard deviation) and median (25–75%). PEXG, pseudoex-
foliation glaucoma; IOP, intra-ocular pressure; CCT, central corneal thickness; AL, axial lenght of
the eye; ACD, anterior chamber depth.
Table 2. Comparison of Schlemm’s canal parameters in patients with pseudoexfoliation
glaucoma and normal controls.
Parameters PEXG patients (n: 41) Controls (n: 41) p
SC lenght (lm) 301.3 (84.1) 349.3 (86.8) 0.044
SC area (lm2) 4000 (3000–5000) 5000 (3000–7750) 0.036
Subjects with observable SC (n) 29 (70.7%) 36 (87.8%) NS
Subjects with measurable
SC area (n)
26 (63.4%) 34 (82.9%) 0.046
Values were presented as mean (standard deviation) and median (25–75%). PEXG, pseudoex-
foliation glaucoma; SC, Schlemm’s canal.
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As IOP increases, the TM expands
into the lumen of the SC and causes
a concomitant narrowing of the
lumen (Johnstone & Grant 1973). In
another study by Kagemann et al.
(2014a,b), they reported that IOP
elevation in healthy subjects reduces
SC cross-sectional area. In our study,
however, the mean IOP values were
similar in PEX glaucoma group and
in controls. Also, we did not find any
correlation between IOP and SC
measurements.
Shi et al. (2014) studied the mor-
phological changes in SC in treated and
newly diagnosed untreated glaucoma-
tous eyes by swept source OCT. In
their study, the area, circumference and
long diameter of SC were found
smaller in untreated patients than in
treated patients. They stated that after
the drug therapy, the IOP would be
reduced, which could lead to expansion
of the SC, causing the area and cir-
cumference to become larger. As our
sample size was small and the number
of newly diagnosed untreated cases was
low, we could not determine the mor-
phological changes in the SC with
antiglaucomatous drug treatment. This
was a limitation of our study.
In this study, the investigators were
confident that the SC could be
observed in up to 87% of scans in
control group and 70% in PEX glau-
coma group. Consistent with the
results of our study, Usui et al.
(2011) reported that the SC was
observable in 90% of normal cases.
On the other hand, Kagemann et al.
(2010) identified the SC in 100% of
normal subjects.
In the literature, it is reported that
the gradual build-up of PEX material
in the juxtacanalicular tissue correlates
with the IOP level and with the pres-
ence and severity of glaucomatuos
optic nerve damage and may be asso-
ciated with progressive degenerative
changes of SC including narrowing,
fragmentation and obstruction in more
advanced cases (Schl€otzer-Schrehardt
& Naumann 1995, 2006; Gottanka
et al. 1997). In our study, the percent-
age of PEX glaucoma patients with
measurable SC area was 63%, whereas
it was 82% in control group
(p = 0.046). This significant difference
between the percentages of the measur-
able SC area in two groups and nar-
rowing of SC in patients with PEX
glaucoma could be explained, in part,
by the accumulation of PEX material
in the juxtacanalicular tissue. Johnson
et al. (2000) studied the TM and SC
with light and electron microscopy in
patients with PEX syndrome or PEX
glaucoma. They reported that eyes with
PEX tended to have a smaller canal
with increasing severity of disease.
However, they studied only two eyes
with advanced PEX glaucoma. In this
study, the percentage of measurable SC
area in eyes with advanced PEX glau-
coma (stage 3 + 4) was significantly
lower (54%) than that in eyes with
early PEX glaucoma (stage 1 + 2)
(76%) and that in control eyes (82%)
(p = 0.039).
Hong et al. (2013) used SD-OCT to
compare SC area in healthy eyes and
those with primary open-angle glau-
coma in cohorts of Chinese persons.
They used a single line scan, interro-
gating the limbus until a clear view of
SC was obtained. Buller and Johnson
(1994) examined the variability of the
TM in normal and glaucomatous eyes
with light and electron microscopy.
Significant segmental differences were
not found within single eyes in both
groups and they stated that differences
among quadrants were qualitative
rather than quantitative. Usui et al.
(2011) studied SC length, TM length
and TM area in enucleated human eyes
by AS-Fourier domain-OCT. Differ-
ences in parameter measurements were
not statistically significant between
temporal and nasal sections and
between right and left eyes. On the
other hand, previous studies reported
that the SC area can vary dramatically
in different scan locations, even in a
small distance (Kagemann et al. 2010,
2014a,b). It is also emphasized that to
describe SC area, a high density of
radial scans facilitating multiple mea-
surements of SC area, as provided by a
volumetric scan across the region of
interest, is required (Kagemann et al.
2014a,b). Therefore, whether a single
scan measurement could represent the
real SC requires further investigation.
This could be another limitation of our
study.
In conclusion, AS-SD-OCT offers
non-invasive, in vivo measurement of
the SC and it could be used for
investigating the SC changes in patients
with PEX glaucoma.
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